CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV and HCV), performed on the Tigris testing platform, to the -enhanced Ultrio Elite triplex assay performed on the Panther testing platform on July 13, 2020. The implementation date has been moved up to July 7th. Contact your Customer Service Manager if you have any questions!
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...